(Q47321829)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969361%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

An open-label pilot study of the combination therapy of metformin and fluoxetine for weight reduction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969361%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969361%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

M Siavash Dastjerdi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969361%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

F Kazemi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969361%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

A Najafian

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969361%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

M Mohammady

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969361%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

M Amini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969361%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

12 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969361%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Obesity

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969361%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969361%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969361%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

713-717

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969361%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.ijo.0803447

30 December 2019

exact match

0 references

cites work

Overweight, obesity, and health risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

Aetiology of obesity: a striving after wind?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

The effects of orlistat on metabolic parameters and other cardiovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

A systematic review of the clinical effectiveness of orlistat used for the management of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

21 January 2018

Oral Antidiabetic Agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

Beneficial effects of metformin in normoglycemic morbidly obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

Exercise in weight management of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

Treatment of obesity: an update on anti-obesity medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

Weight Gain During Long-Term Treatment of Obsessive-Compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

Meta-analysis: pharmacologic treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

Fluoxetine, a selective inhibitor of serotonin uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

Metformin effects on dipeptidylpeptidase IV degradation of glucagon-like peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

Fluoxetine's effect on weight loss in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

7 January 2021

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

7 January 2021

Pharmacotherapy for obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

7 January 2021

Effect of fluoxetine on food intake of humans living in a residential laboratory

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

7 January 2021

Appraisal of the clinical value of serotoninergic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803447

7 January 2021